购物车
- 全部删除
- 您的购物车当前为空
RWJ-51204是选择性的腺苷 A2A 受体拮抗剂, 是 GABA(A) receptor 的部分激动剂(IC50: 0.2-2 nM)。其具有神经保护和改善运动的功效,可用于帕金森疾病的相关研究。
为众多的药物研发团队赋能,
让新药发现更简单!
RWJ-51204是选择性的腺苷 A2A 受体拮抗剂, 是 GABA(A) receptor 的部分激动剂(IC50: 0.2-2 nM)。其具有神经保护和改善运动的功效,可用于帕金森疾病的相关研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,350 | 现货 | |
5 mg | ¥ 5,630 | 现货 | |
10 mg | ¥ 7,790 | 现货 | |
25 mg | ¥ 11,200 | 现货 | |
50 mg | ¥ 13,800 | 现货 | |
100 mg | ¥ 17,500 | 现货 | |
500 mg | ¥ 34,800 | 现货 |
产品描述 | RWJ-51204 is a selective adenosine A2A receptor antagonist and a partial agonist of GABA(A) receptor (IC50: 0.2-2 nM). It has neuroprotective and movement-improving effects and can be used in research related to Parkinson's disease. |
靶点活性 | GABAA:0.2-2 nM(ki) |
体外活性 | RWJ-51204 binds to receptors with Ki ranging from 0.2 to 0.6 nM in the cerebral cortex, cerebellum, or medulla-spinal cord.[1] |
体内活性 | RWJ-51204 is effective in the conflict test in monkeys (ED50 of approximately 0.5 mg/kg p.o.). RWJ-51204 is orally active in anxiolytic efficacy tests. RWJ-51204 effectively impairs rotarod performance in rats (ED50 = 0.12 mg/kg), and all rats given RWJ-51204 orally at 30 mg/kg exhibit sedation, reduced skeletal muscle tone, and impairment of rotarod performance. [1] |
分子量 | 399.39 |
分子式 | C21H19F2N3O3 |
CAS No. | 205701-85-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 3.99 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.